0
A new Pfizer Animal Health was unveiled last week as Pfizer's acquisition of Wyeth, including its subsidiary Fort Dodge Animal Health, was completed. Pfizer Animal Health is now the world’s leader in the discovery, development, manufacture and sales of veterinary vaccines and medicines for livestock and companion animals.The acquisition of many of Fort Dodge’s U.S. products allows Pfizer Animal Health to greatly diversify its U.S. portfolio, as well as broaden its offering in all animal health segments.
Pfizer Animal Health now offers an enhanced portfolio in beef, moredairy, and companion animals, as well as a redefined product line for swine, equine and poultry.
“We’re extremely proud to offer our customers even more best-inclass and innovative products,” said Clint Lewis, president of U.S Operations for Pfizer Animal Health. “The products, services and expertise we are gaining strengthen what is already a robust U.S. portfolio and will enhance our leading position in the animal health marketplace.”
For the swine market, Pfizer Animal Health will offer a comprehensive range of solutions and services to strengthen its offering with the full line of SUVAXYN® brands, including SUVAXYN PCV-2 vaccine for circovirus. This addition rounds out an already broad product line that includes RESPISURE®, FLUSURE®, DRAXXIN®, and EXCEDE®.
http://www.pfizeranimalhealth.com/sites/pah/News%20%20Media%20Content/PAH%20US%20PRESS%20RELEASE%2010-19-09.pdf
